Bellerophon Therapeutics, Inc.
BLPH
Revenue
0.00
0.000.00%
-Assets
4.98M
▼-6.27M▼-55.72%
3 Months ChangeLiabilities
1.26M
▼-4.37M▼-77.66%
3 Months ChangeFree Cash Flow
-3.66M
▼-3.66M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-03-04
Form 8-K
ID: 0001104659-24-030552
2024-01-30
Form 8-K
ID: 0001104659-24-007999
2024-01-22
Form 8-K
ID: 0001104659-24-005554
2024-01-10
Form 8-K
ID: 0001104659-24-002968
2023-12-12
Form 8-K
ID: 0001104659-23-125371
2023-11-21
Form 8-K
ID: 0001104659-23-120348
2023-11-14
Form 10-Q
ID: 0001558370-23-019044
2023-10-13
Form 8-K
ID: 0001104659-23-109006
2023-10-13
Form 8-K
ID: 0001104659-23-108988
2023-08-14
Form 10-Q
ID: 0001558370-23-014867